Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 835,080 | 370,829 | 599,691 | 122,420 | 80,304 |
| Marketable Securities | 289,668 | 803,083 | 479,369 | 206,120 | 122,882 |
| Receivables | 90,879 | 49,044 | 29,468 | 5,228 | 3,977 |
| Inventories | 171,379 | 125,445 | 83,605 | 12,813 | 0 |
| Other current assets | 81,907 | 77,782 | 36,511 | 26,895 | 17,380 |
| TOTAL | $1,468,913 | $1,426,183 | $1,228,644 | $373,476 | $224,543 |
| Non-Current Assets | |||||
| PPE Net | 129,620 | 97,024 | 43,156 | 37,801 | 37,344 |
| Investments And Advances | 0 | 0 | 21,809 | 4,751 | 783 |
| Intangibles | 12,497 | 11,574 | 14,355 | 8,076 | 6,642 |
| Other Non-Current Assets | 211,792 | 107,294 | 0 | 0 | 4,470 |
| TOTAL | $353,909 | $215,892 | $79,320 | $50,628 | $49,239 |
| Total Assets | $1,822,822 | $1,642,075 | $1,307,964 | $424,104 | $273,782 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 6,175 | 10,108 | 5,936 |
| Accounts payable and accrued liabilities | 68,094 | 33,829 | 8,467 | 29,690 | 20,234 |
| Accrued Expenses | 185,527 | 134,095 | 68,982 | 31,016 | 29,053 |
| Other current liabilities | 7,843 | 5,766 | 1,392 | 1,305 | 1,275 |
| TOTAL | $264,767 | $173,690 | $88,332 | $75,422 | $62,294 |
| Non-Current Liabilities | |||||
| Long Term Debt | 681,900 | 420,554 | 424,876 | 6,042 | 14,969 |
| Deferred Revenues | 3,303 | N/A | 3,316 | 3,303 | 3,303 |
| Other Non-Current Liabilities | 57,968 | 15,555 | 0 | 0 | 0 |
| TOTAL | $739,868 | $436,109 | $430,415 | $11,991 | $21,141 |
| Total Liabilities | $1,004,635 | $609,799 | $518,747 | $87,413 | $83,435 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,777 | 71,292 | 64,978 | 54,813 | 45,666 |
| Common Shares | 8 | 7 | 6 | 5 | 5 |
| Retained earnings | -2,294,001 | -1,578,926 | -1,217,008 | -1,166,320 | -899,055 |
| Other shareholders' equity | 50 | -99 | -379 | -120 | -111 |
| TOTAL | $818,187 | $1,032,276 | $789,217 | $336,691 | $190,347 |
| Total Liabilities And Equity | $1,822,822 | $1,642,075 | $1,307,964 | $424,104 | $273,782 |